Current News

Contact | Print version | PDF version | Send article | RSS feed

MetaMorphix Collaborates With Sequenom to Develop Animal Predictive Diagnostics

09 Nov 2005 - Sequenom, Inc. and MetaMorphix, Inc. (MMI) announced that MMI has chosen to use Sequenom's MassARRAY(R) genetic analysis system as the technical platform to aid it in completing preliminary commercialization field trials of its pipeline of new DNA-based animal predictive diagnostic tools. The first full commercial introduction of MMI's products for its corporate partner Cargill, Inc. is expected during 2006 and eventually could result in MMI conducting predictive diagnostic analysis for millions of cattle raised in the United States.
 
The relationship focuses on MMI utilizing Sequenom's high throughput MassARRAY system for animal DNA screening and selection. MMI has completed the research phase and is entering into commercialization trials with products targeting two strategic markets -- livestock and companion animals. In livestock, MMI has developed, for Cargill, a management tool that will help feedlot operators select animals that answer consumer demands for consistency and quality in their meat products. In companion animals, MMI has developed single nucleotide polymorphism-based products that will accurately inform dog owners, breeders and registries of the parental verification and breed makeup of mixed as well as purebred dogs.
 
"The scope of our many applications is large and could potentially change the future of livestock reproduction by increasing production efficiency and responding to consumer demands for quality meat. In the companion animal health industry, MMI's products will enable pet owners to anticipate their pet's health problems and manage their well being accordingly," stated Ed Quattlebaum, Chief Executive Officer of MMI.